Contact Details
Matt Riley - Head of Investor Relations & Corporate Communications
NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022
By:
TheNewswire.com
October 21, 2022 at 11:00 AM EDT
Contact DetailsMatt Riley - Head of Investor Relations & Corporate Communications Company Websitehttps://agiletherapeutics.com/ More NewsView More
How Did Peter Thiel-Backed Crypto Exchange Bullish's IPO Go?
August 14, 2025
Mercury Systems Up 27%: Financials Send Investors a Clear Signal
August 14, 2025
Deere’s Sell-Off Could Be a Long-Term Buying Chance
August 14, 2025
Nuclear Reactors on the Moon? Why BWX Technologies Is Soaring
August 14, 2025
Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore
August 14, 2025
Via MarketBeat
Tickers
IT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|